» Articles » PMID: 8830801

Comparative Genotoxicity of Six Salicylic Acid Derivatives in Bone Marrow Cells of Mice

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 1996 Aug 1
PMID 8830801
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In vivo sister chromatid exchange (SCE) and chromosome aberrations (CA) were carried out for six salicylic acid derivatives in bone marrow cells of mice. Six salicylic acid derivatives, namely acetyl salicylic acid (aspirin), salicylic acid, salicylamide, sodium salicylate, diflunisal and niclosamide, were used for these experiments. Drugs were administered both intraperitoneally (i.p.) and orally by gavage. Out of these six salicylic acid derivatives tested, only diflunisal and niclosamide showed genotoxicity as measured by both SCE and CA assays. Acetyl salicylic acid and sodium salicylate showed weak genotoxicity as measured by SCE and CA, respectively, only at the highest dose tested.

Citing Articles

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.

Wang Z, Ren J, Du J, Wang H, Liu J, Wang G Int J Mol Sci. 2022; 23(24).

PMID: 36555754 PMC: 9782559. DOI: 10.3390/ijms232416116.


Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.

Giri A, Das A, Sarkar A, Giri A Genes Environ. 2020; 42:25.

PMID: 32884603 PMC: 7462746. DOI: 10.1186/s41021-020-00164-0.


N-substituted phenylbenzamides of the niclosamide chemotype attenuate obesity related changes in high fat diet fed mice.

Bhagat H, Compton S, Musso D, Laudeman C, Jackson K, Yi N PLoS One. 2018; 13(10):e0204605.

PMID: 30359371 PMC: 6201879. DOI: 10.1371/journal.pone.0204605.


Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.

Gangrade A, Pathak V, Augelli-Szafran C, Wei H, Oliver P, Suto M Int J Mol Sci. 2018; 19(5).

PMID: 29783777 PMC: 5983770. DOI: 10.3390/ijms19051524.


SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Li Y, Oliver P, Lu W, Pathak V, Sridharan S, Augelli-Szafran C Cancer Lett. 2017; 389:41-48.

PMID: 28043913 PMC: 5544029. DOI: 10.1016/j.canlet.2016.12.030.